NCT00252993View on ClinicalTrials.gov

12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting

PHASE2TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

March 31, 2006

Conditions
Vomiting
Interventions
DRUG

DDP225

Trial Locations (6)

36693

University of South Alabama, Mobile

39216

University of Mississippi Medical Center, Jackson

43051

University of Kansas Medical Center, Kansas City

55905

Mayo Clinic, Rochester

63122

Washington University, St Louis

85259

Mayo Clinic, Scottsdale

Sponsors
All Listed Sponsors
lead

Dynogen Pharmaceuticals

INDUSTRY